FDA
approval
· 2019-10-07
FDA Approved: MS CONTIN — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
FDA approved a supplemental application for MS CONTIN (morphine sulfate) submitted by Rhodes Pharmaceuticals L.P.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MS CONTIN (MORPHINE SULFATE)